PNC-27 Research Review: p53-Derived Membrane-Acting Peptide, HDM-2 Targeting, and Cancer-Cell Necrosis
A research-focused overview of PNC-27, a membrane-acting anticancer research peptide combining a p53-derived HDM-2-binding domain with a membrane-penetrating leader, studied for selective cancer-cell necrosis across in-vitro and preclinical tumor models.